Brief: Scinai Expands CDMO Business With $5.1 Million Development And Clinical Manufacturing Agreement
13/10/2026 12:13
BRIEF-Scinai Expands CDMO Business With $5.1 Million Development And Clinical Manufacturing Agreement Oct 13 (Reuters) - Scinai Immunotherapeutics Ltd 2F50y.F:
SCINAI EXPANDS CDMO BUSINESS WITH $5.1 MILLION DEVELOPMENT AND CLINICAL MANUFACTURING AGREEMENT
SCINAI IMMUNOTHERAPEUTICS - AGREEMENT SUPPORTS DEVELOPMENT IN 2026 AND CLINICAL MANUFACTURING IN 2027
SCINAI IMMUNOTHERAPEUTICS - POTENTIAL ADDITIONAL CLINICAL MANUFACTURING INDICATIVE VALUE $5.85 MILLION FOR LATE 2027-H1 2028
Source text: ID:nPnbLT4pPa
Further company coverage: [2F50y.F]